SCWorx Corp. (Nasdaq: WORX) announced today that it confirms previously disclosed plans to distribute COVID-19 Rapid Testing Units. Previously, the company announced receiving a committed purchase order from Rethink My Healthcare, a U.S.-based virtual healthcare network, for two million COVID-19 Rapid Testing Units, with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week.
Under the previously disclosed purchase order, SCWorx will supply Rethink My Healthcare with IgM/IgG Rapid Detection Kits. SCWorx continues to anticipate receiving the first 2 million rapid detection kits within approximately two weeks and looks forward to providing incremental updates as they become available.
Two Steps to Controlling the Hot Zone
RiverSpring Living Breaks Ground on River's Edge Senior Living Community
Encompass Health Reveals Plans to Build Inpatient Rehabilitation Hospital in Post Falls, Idaho
Creating Compassionate Spaces in Healthcare
Study Shows Connection Between Odor and Patient Experience